Multiple epidemiological evidence correlates low adiponectin level, characterizing obesity status, with an enhanced risk of cancer development, such as kidney, esophagus, prostate, thyroid, pancreatic, colorectal, breast cancer and many others [27]. Here, ADIPOQ is linked to obesity disorder.